Development and in vitro evaluation of a mucoadhesive oral delivery system for antisense oligonucleotides

Scientia Pharmaceutica

Volumn 71, Issue 3, 2003, Pages 165-177

  Bernkop Schnürch, Andreas ^a   Telsnig, Julia ^a   Hornof, Margit ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antisense oligonucleotides; Mucoadhesive polymers; Oral drug delivery; Thiomers

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYSTEINE; DRUG CARRIER; INTESTINE ENZYME; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PENETRATION ENHANCING AGENT; POLYACRYLIC ACID; POLYACRYLIC ACID CYSTEINE CONJUGATE; POLYCARBOPHIL; POLYMER; THIOMER; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; COVALENT BOND; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG PENETRATION; DRUG STABILITY; GUINEA PIG; IN VITRO STUDY; INTESTINE FLUID; INTESTINE MUCOSA; MATRIX TABLET; NONHUMAN; TABLET FORMULATION;

EID: 0141682788     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.aut-03-17     Document Type: Article

References (21)

1. Raoof A A, Ramtoola Z, McKenna B, Yu R Z, Hardee G, Geary R S. Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs. Eur. J. Pharm. Sci. 2002;17:131-138.
2. Nicklin P L, Bayley D, Giddings J, Craig S J, Cummins L L, Hastewell J G, Phillips J A. Pulmonary bioavailability of a phosphorothioate oligonucleotide (CGP 64128A): comparison with other delivery routes. Pharm. Res. 1998;15:583-591.
3. Geary R S, Khatsenko O, Bunker K, Crooke R, Moore M, Burckin T, Truong L, Sasmor H, Levin A A. Absolute bioavailability of 2′ -O-(2-methoxyethyl)-modified antisense oligonucleotides following intraduodenal instillation in rats. J. Pharmacol. Exp. Ther. 2001;293:898-904.
4. Kurreck J, Wyszko E, Gillen C, Erdmann V A. Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res. 2002;30:1911-1918.
5. Agrawal S, Zhang X, Lu Z, Zhao H, Tamburin J M, Yan J, Cai H, Diasio R B, Habus I, Jiang Z, et al. Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administration. Biochem. Pharmacol. 1995;50:571-576.
6. Khatsenko O, Morgan R, Truong L, York-Defalco C, Sasmor H, Conklin B, Geary R S. Absorption of antisense oligonucleotides in rat intestine: effect of chemistry and length. Antisense Nucleic Acid Drug Dev. 2000;10:35-44.
7. Luessen H L, de Leeuw B J, Langemeyer M W, de Boer A G, Verhoef J C, Junginger H E. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm. Res. 1996;13:1668-1672.
8. Kast C E, Guggi D, Langoth N, Bernkop-Schnürch A. Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil. Pharm. Res. 2003;20:931-936.
9. Takeuchi H, Matsui Y, Yamamoto H, Kawashima Y. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J. Control. Release 2003;86:235-242.
10. Marschütz M K, Caliceti P, Bernkop-Schnürch A. Design and in vivo evaluation of an oral delivery system for insulin. Pharm. Res. 2000;17:1468-1474.
11. Guggi D, Kast C E, Bernkop-Schnürch A. In vivo evaluation of an oral calcitonin delivery system for rats based on a thiolated chitosan matrix. Proceed. 11th Inter. Pharm. Technol. Symp. 2002;41-42.
12. Marschütz M K, Bernkop-Schnürch A. Thiolated polymers: self-crosslinking properties of thiolated 450 kDa poly(acrylic acid) and their influence on mucoadhesion. Eur. J. Pharm. Sci. 2002;15:387-394.
13. Clausen A E, Kast C E, Bernkop-Schnürch A. The role of glutathione in the permeation enhancing effect of thiolated polymers. Pharm. Res. 2002;19:602-608.
14. Bernkop-Schnürch A, Schwarz V, Steininger S. Polymers with thiol groups: A new generation of mucoadhesive polymers? Pharm. Res. 1999;16:876-881.
15. Bernkop-Schnürch A, Kast C E, Richter M F. Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. J. Control. Rel. 2001;71:277-285.
16. Hughes J A, Avrutskaya A V, Brouwer K L, Wickstrom E, Juliano R L. Radiolabeling of methylphosphonate and phosphorothioate oligonucleotides and evaluation of their transport in everted rat jejunum sacs. Pharm. Res. 1995;12:817-824.
17. Hornof M D, Bernkop-Schnürch A. In vitro evaluation of the permeation enhancing effect of polycarbophil - cysteine conjugates on the cornea of rabbits. J. Pharm. Sci. 2002;91:2588-2592.
18. Leitner V M, Walker G F, Bernkop-Schnürch A. Thiolated polymers: Evidence for the formation of disulphide bonds with mucus glycoproteins. Eur. J. Pharm. Biopharm. 2003;in press.
19. Bernkop-Schnürch A, König V, Leitner V, Krauland A, Brodnik I. Preparation and Characterisation of Thiolated Poly(methacrylic acid) - Starch Compositions. Eur. J. Pharm. Biopharm. 2003;in press.
20. Clausen A E, Bernkop-Schnürch A. Development and in vitro evaluation of a peptide drug delivery system based on thiolated polycarbophil. Pharm. Ind. 2001;63:312-317.
21. Coupe A J, Davis S S, Wilding I R. Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm. Res. 1991;8:360-364.